No Data
No Data
Goldman Sachs Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Cuts Target Price to $82
Results: GE HealthCare Technologies Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
ESTRO 2025 Congress: GE HealthCare to Expand Its Radiation Oncology Portfolio and Introduce New AI-enabled Solutions
J.P. Morgan Remains a Hold on GE Healthcare Technologies Inc (GEHC)
J&J-backed HistoSonics Explores Sale at $2.5 Billion Valuation, FT Reports
Research Alert: CFRA Keeps Hold Opinion On Shares Of Ge Healthcare Technologies Inc.